Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
Recruiting · NCT04912843 · Registry updated 2022-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Leber hereditary optic neuropathy, Nutritional and Metabolic Diseases, cranial nerve neuropathy, eye disorder, hereditary disease, hereditary optic atrophy, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, optic atrophy, optic nerve disorder | Recruiting | Phase 2 / Phase 3 | 2022-11-14 | NCT04912843 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Wuhan Neurophth Biotechnology Limited Company | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tongren Hospital, Capital Medical University | Beijing | China | 15 |